- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01604616
Short Term Postoperative Tamponade Using Perfluorocarbon Liquid for Giant Retinal Tears
May 22, 2012 updated by: Ziv Hospital
The purpose of the article is, to investigate the efficacy and safety of perfluorocarbon liquid (PFCL) ,as a short term postoperative tamponade for treating retinal detachment ,associated with giant retinal tears.
Study Overview
Status
Unknown
Conditions
Detailed Description
a retrospective study wich compared 2 groups that had giant tear repair in one group, PFCL was left for few days as an intermediate measure until silicone oil or SF6 gas was used to reattach the retina ,and in the control group SF6 or Silicone oil were used, with no PFCL.
Study Type
Observational
Enrollment (Anticipated)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Safed, Israel
- Recruiting
- Ziv Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
man and women above the age of 18 years
Description
Inclusion Criteria:
- above 18 years of age
- retinal tear at least of 3 clock hours.
Exclusion Criteria:
- less than 18 years of age
- Retinal tear less than 3 hours
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
PCFL GROUP
patients in this group had the PFCL for a period of 7-10 days before it was replaced by SF6 gas or silicone oil
|
control group
in thos group no PFCL was left in the eye and either SF6 or silicone oil was the definitive treatment at the time of the retinal detachment surgery repair.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 1998
Study Completion (ANTICIPATED)
June 1, 2012
Study Registration Dates
First Submitted
May 21, 2012
First Submitted That Met QC Criteria
May 22, 2012
First Posted (ESTIMATE)
May 23, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
May 23, 2012
Last Update Submitted That Met QC Criteria
May 22, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0032-12-ZIV
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Retinal Detachment
-
The S.N. Fyodorov Eye Microsurgery State InstitutionUnknownRhegmatogenous Retinal DetachmentRussian Federation
-
Meir Medical CenterUnknownRhegmatogenous Retinal DetachmentIsrael
-
University of Campinas, BrazilCompletedRhegmatogenous Retinal Detachment
-
Ain Shams UniversityNot yet recruitingRhegmatogenous Retinal Detachment
-
Shahid Beheshti University of Medical SciencesUnknownPseudophakic Retinal Detachment | Aphakic Retinal DetachmentIran, Islamic Republic of
-
Dar El Oyoun HospitalCairo UniversityCompletedRetinal Detachment Multiple BreaksEgypt
-
Universidade Federal do ParanáCompletedRhegmatogenous Retinal Detachment
-
Singapore National Eye CentreCompleted
-
Samsung Medical CenterCompletedRhegmatogenous Retinal Detachment
-
Vitreous -Retina- Macula Consultants of New YorkRegeneron PharmaceuticalsWithdrawnFibrovascular Pigment Epithelial DetachmentUnited States